Novartis India Limited

Healthcare · Pharmaceuticals & Biotechnology

NSE: NOVARTIND BSE: 500672

₹1919.00

Sept. 30, 2026 · NSE · nse_bhavcopy

Peers in Pharmaceuticals & Biotechnology

The largest companies in the same industry by market cap. This company ranks #61 of 184. PE, ROE, 1Y return and scores come from the daily/weekly precomputed snapshot.

Company	Market cap (₹ Cr)	PE (TTM)	ROE	1Y return	Div. yield	Quality	Valuation	Momentum
Sun Pharmaceutical Industries Limited	435,863	146.5	13.7%	11.0%	—	72	8	30
Divi's Laboratories Limited	246,660	83.9	15.3%	62.7%	0.32%	70	4	51
Torrent Pharmaceuticals Limited	162,454	78.2	12.2%	34.6%	0.79%	56	0	31
Zydus Lifesciences Limited	115,910	33.3	17.3%	17.2%	0.09%	74	24	84
Cipla Limited	108,736	35.4	11.2%	-11.0%	0.97%	73	29	62
Laurus Labs Limited	106,969	122.5	17.1%	127.1%	—	78	24	53
Mankind Pharma Limited	103,406	47.4	11.7%	2.6%	—	68	12	86
Dr. Reddy's Laboratories Limited	102,916	154.7	10.9%	-0.9%	—	62	33	71
Novartis India Limited (this stock)	4,738	48.4	11.4%	185.5%	—	68	2	51

Valuation multiples

Current only. Market cap is the whole company's; sales/EBITDA are trailing-twelve-month standalone; debt and cash come from the latest filed standalone balance sheet (March 31, 2026). EBITDA = PBT + interest + depreciation.

Enterprise value

₹4,686 Cr

EV / EBITDA

33.8x

EV / Sales

12.64x

Market cap / Sales

12.79x

Earnings yield

2.06%

Quarterly Financials

Download CSV

Standalone Consolidated

↑ Positive

Quarterly Revenue

Jun 2026 quarterly revenue is Rs 113 Cr, up 14.7% YoY.

↑ Positive

Quarterly Net Profit

Jun 2026 quarterly net profit is Rs 32 Cr, up 16.6% YoY.

Period end	Revenue (₹ Cr)	PBT (₹ Cr)	Net profit (₹ Cr)	Basic EPS
June 30, 2026	104	43	32	₹13.0500
March 31, 2026	91	30	25	₹10.2300
Dec. 31, 2025	86	30	16	₹6.5200
Sept. 30, 2025	90	33	24	₹9.8100
June 30, 2025	88	37	28	₹11.1900
March 31, 2025	84	34	29	₹11.8700
Sept. 30, 2024	87	28	20	₹8.2700
June 30, 2024	92	34	26	₹10.4200
March 31, 2024	81	21	15	₹5.9500
Dec. 31, 2023	85	41	27	₹10.7610
Sept. 30, 2023	79	32	24	₹9.5900
June 30, 2023	91	28	20	₹8.2100
March 31, 2023	76	23	25	₹10.1300

Quarterly income statement (standalone, ₹ Cr)

Indicator	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23
Total income (before exceptional items)	113	101	95	100	98	95	97	103	92	106	96	103	92
Operating revenue	104	91	86	90	88	84	87	92	81	85	79	91	76
Other income	9	10	9	9	11	11	10	10	10	22	17	12	16
Operating expenses	69	70	64	66	60	60	69	68	70	65	62	73	67
Operating profit	35	21	22	24	27	24	18	24	11	20	17	17	9
Operating profit margin	33.6%	22.8%	26.0%	26.4%	31.1%	28.5%	20.6%	26.0%	13.8%	23.4%	21.5%	19.1%	12.2%
Depreciation	0	0	0	1	1	1	1	1	0	0	1	2	2
Interest	0	0	1	0	0	0	0	0	0	0	1	0	0
Exceptional items, gain / (loss)	—	—	—	—	—	—	—	—	—	—	—	—	—
Profit before tax	43	30	30	33	37	34	28	34	21	41	32	28	23
Tax	11	5	14	8	10	5	7	8	7	15	9	8	-2
Net profit	32	25	16	24	28	29	20	26	15	27	24	20	25
EPS	13.05	10.23	6.52	9.81	11.19	11.87	8.27	10.42	5.95	10.76	9.59	8.21	10.13
Net profit (TTM)	98	93	97	102	103	90	87	91	85	96	77	71	103
EPS (TTM)	39.61	37.75	39.39	41.14	41.75	36.51	35.40	36.72	34.51	38.69	31.01	28.85	41.85

Total income excludes exceptional items, which are shown on their own row. Trendlyne and Screener fold exceptional items into revenue or other income, so their totals differ from this table by exactly that row.

Annual Financials

Annual income statement (standalone, ₹ Cr; CAGR to the latest year)

Indicator	CAGR 3Y	CAGR 5Y	Mar 26	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18	Mar 17
Total income (before exceptional items)	-3.5%	-1.1%	393^†	397^†	437^†	433^†	414^†	474^†	569^†	736^†	726^†
Operating revenue	-2.2%	-1.5%	354^†	335^†	379^†	400^†	381^†	438^†	491^†	564^†	656^†
Other income	—	—	39^†	62^†	58^†	33^†	33^†	36^†	78^†	172^†	70^†
Operating expenses	—	—	260^†	270^†	314^†	373^†	355^†	426^†	—	570^†	630^†
Operating profit	13.1%	28.6%	94^†	65^†	65^†	27^†	27^†	12^†	—	-6^†	26^†
Operating profit margin	—	—	26.6%^†	19.5%^†	17.2%^†	6.8%^†	7.0%^†	2.7%^†	—	-1.1%^†	4.0%^†
Depreciation	—	—	2^†	3^†	6^†	10^†	12^†	13^†	3^†	3^†	4^†
Interest	—	—	1^†	1^†	2^†	5^†	8^†	6^†	—	6^†	1^†
Exceptional items, gain / (loss)	—	—	0^†	0^†	0^†	-50^†	0^†	0^†	0^†	0^†	0^†
Profit before tax	4.0%	26.5%	130^†	123^†	115^†	-4^†	40^†	29^†	86^†	158^†	92^†
Tax	—	—	36^†	38^†	12^†	-0^†	19^†	19^†	34^†	79^†	35^†
Net profit	-3.4%	34.8%	93^†	85^†	103^†	-4^†	21^†	10^†	52^†	78^†	57^†
EPS	-3.4%	34.8%	37.75^†	34.51^†	41.85^†	-1.51^†	8.47^†	4.09^†	—	—	—

^† Derived: the sum of that fiscal year's four quarterly filings (a real annual filing is used wherever one exists). Checked against filed annual figures, the sum lands within 0.5% for about 94% of company-years.

Annual ratios (standalone)

Ratio	Mar 26	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18	Mar 17
Operating margin	26.6%^†	19.5%^†	17.2%^†	6.8%^†	7.0%^†	2.7%^†	—	-1.1%^†	4.0%^†
EBIT margin	36.9%^†	37.1%^†	30.9%^†	0.3%^†	12.5%^†	8.0%^†	—	28.9%^†	14.1%^†
PBT margin	36.6%^†	36.7%^†	30.5%^†	-1.0%^†	10.5%^†	6.5%^†	17.5%^†	27.9%^†	14.0%^†
Net margin	26.3%^†	25.4%^†	27.3%^†	-0.9%^†	5.5%^†	2.3%^†	10.6%^†	13.9%^†	8.7%^†
Interest coverage	103.90x^†	83.44x^†	66.93x^†	0.21x^†	6.21x^†	5.48x^†	—	29.48x^†	128.40x^†
Dividend payout	0.0%^†	29.0%^†	23.9%^†	—	0.0%^†	0.0%^†	—	—	—
Earnings retention	100.0%^†	71.0%^†	76.1%^†	—	100.0%^†	100.0%^†	—	—	—
Current ratio	5.30x	—	—	—	—	—	—	—	—
Quick ratio	4.93x	—	—	—	—	—	—	—	—
Debt to equity	0.00x	—	—	—	—	—	—	—	—
Return on equity	11.4%^†	—	—	—	—	—	—	—	—
Return on assets	9.5%^†	—	—	—	—	—	—	—	—
Return on capital employed	15.7%^†	—	—	—	—	—	—	—	—
Asset turnover	0.36x^†	—	—	—	—	—	—	—	—

Margins and asset turnover use operating revenue (interest earned for banks, excluding other income), not total income. Liquidity, leverage and return ratios need a filed standalone balance sheet, which exists only for recent years; returns use year-end equity/assets. Dividend payout is shown only for companies with a dividend record. † = built from a summed fiscal year.

Revenue Mix

Data unavailable.

Cash Flow

Year ended	Operating (₹ Cr)	Investing (₹ Cr)	Financing (₹ Cr)	Capex (₹ Cr)	Free Cash Flow (₹ Cr)
March 31, 2026	47	18	-64	0	46
March 31, 2025	75	-3	-64	0	75

Balance Sheet (standalone)

Year ended	Total Assets (₹ Cr)	Total Equity (₹ Cr)	Reserves (₹ Cr)	Borrowings, Current (₹ Cr)	Borrowings, Non-current (₹ Cr)	Current Assets (₹ Cr)	Current Liabilities (₹ Cr)	Cash & Equivalents (₹ Cr)	Net Block (₹ Cr)	Inventory (₹ Cr)
March 31, 2026	978	818	805	0	0	768	145	52	3	53
March 31, 2025	948	785	773	0	0	746	142	52	5	41

Financial charts

Trend charts drawn from the standalone income-statement and ratio tables above (oldest year on the left); a gap means that period has no figure. Annual years marked † in the tables are derived from four quarters.